Home » Qiagen to Transfer Transplant Dx Rights to Olerup

Qiagen to Transfer Transplant Dx Rights to Olerup

Jun 16, 2009

NEW YORK (GenomeWeb News) – Qiagen today said that it will transfer distribution rights for the Olerup line of molecular transplantation testing products to LinkMed subsidiary Olerup International on July 1.

The testing products included in the agreement are used for DNA HLA typing. The transfer of assets will include all Olerup SSP HLA sales infrastructure and offices in Austria.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Articles

Nov 12, 2014

Diaxonhit, One Lambda Renew Distribution Partnership for Transplant Dx

Jun 18, 2014

Stanford Team Publishes Validation of Circulating DNA Sequencing for Heart Transplant Rejection Dx

Premium
Dec 15, 2014

Roche Cobas Assays Get Additional CE Claims for Organ, Tissue Testing

Nov 18, 2014

Stanford Team Tests NGS of Circulating cfDNA to Diagnose Organ Transplantation Rejection and Infection

Premium
Sep 11, 2014

Direct PCR Tapped for Easier, Cheaper PGx Testing of HIV Drug-response Marker

Premium
Jun 25, 2014

GenDx Receives CE-IVD Marking for HLA Product; Inks Deal with PacBio

Premium

The Scan

This Week in Nature

In Nature this week: omic analysis of permafrost microbes, hookworm genome, and more.

Bits of Evidence

Biologists turn to environmental DNA sampling to determine whether elusive or invasive species are shedding DNA in a given area.

Return on Microbiome Research

Rob Knight writes at Scientific American that microbiome studies are about to break out of the laboratory.

Harold Varmus to Leave NCI

Harold Varmus, the director of the National Cancer Institute, has announced that he is stepping down after nearly five years.

What's Popular?

In Clinical & Translational

  1. Sequenom to Launch VisibiliT for Average-Risk Pregnancies Outside US, Expand MaterniT21 Plus

    Premium

  2. Startup Diassess Wins New NIH Grant to Develop POC Nucleic Acid Test for Chlamydia

    Premium

  3. Thermo Fisher Completes Listing of Ion PGM Dx System with FDA

  4. Contextual Genomics to Beta Test Affordable Cancer Panel for Personalizing Cancer Therapy in Canada

    Premium

  5. Interactive Biosoftware Adds High-Throughput Variant Annotation Software to Portfolio

    Premium

Sponsorships

Privacy Policy.  Copyright © 2015 Genomeweb LLC.  All Rights Reserved.